Protein Tyrosine Kinase/RTK
-
BA2881 AG-825Summary: AG-825 is a selective, ATP-competitive, inhibitor of tyrosine phosphorylation. - BA2873 LuxeptinibSummary: Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent inhibitor.
- BA2864 AlofanibSummary: Alofanib (RPT835) is a potent and selective variant inhibitor of fibroblast growth factor receptor 2.
-
BA2848 Wu-5Summary: Wu-5 is a USP10 inhibitor. - BA2847 BO-264Summary: BO-264 is a potent, orally active inhibitor of transformed acidic convoluted helix 3.
- BA2825 TL02-59Summary: TL02-59 is an orally active, selective inhibitor of Src-family kinases.
- BA2818 T025Summary: T025 is an orally effective inhibitor.
- BA2806 SC-43Summary: SC-43, a derivative of Sorafenib, is a potent agonist with oral activity.
- BA2785 BMS-536924Summary: BMS-536924 is an orally active, competitive and selective inhibitor of insulin-like growth factor receptor kinase and insulin receptor at 100nM and 73nM, respectively.
- BA2776 GSK2256098Summary: GSK2256098 is a selective kinase inhibitor.